Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-11

Clinical Trial Update: The Role of R-Alpha Lipoic Acid in the Treatment of Atherosclerotic Vascular Disease [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on R-Alpha Lipoic Acid for atherosclerotic vascular disease, conducted in Phase 2 and Phase 3. The study, sponsored by Oregon State Univ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • R-Alpha Lipoic Acid (R-alpha-lipoic acid)

Snippet

Sponsor: Oregon State University | Conditions: Atherosclerosis | Phase 2, Phase 3 | Status: COMPLETED